5A-DHT is converted from testosterone by 5-α reductase in the ovaries and peripherally in fat tissue.
The metabolic prioritization for alpha or beta reductase activity within the progesterone pathway may be confirmatory of a general preference of metabolism. Comparing these results with the metabolic preference of androgens and corticoids may provide additional insight.
The metabolic prioritization for alpha or beta reductase activity within the progesterone pathway may be confirmatory of a general preference of metabolism. Comparing these results with the metabolic preference of androgens and corticoids may provide additional insight.
the most important progesterone metabolite
Metabolites of progesterone are measured in urine, including 5b-pregnanediol and 5a-pregnanediol. 5b-pregnanediol is inactive in the body but is the major metabolite of progesterone. 5a-pregnanediol is often a metabolite of more interest, as it can cross the blood brain barrier and up-regulate GABA activity and is considered neuroprotective to the brain. Both taken together represent the major metabolic end points for progesterone and can be used to represent total progesterone production. Progesterone is produced by the corpus luteum following ovulation and to a lesser extent by the adrenal glands in both sexes. While found in the urine in small amounts, progesterone can be seen as a clinical marker of luteul activity and theraputic oral progesterone administration. The most important progesterone metabolite, pregnanediol (PDL), can serve as a urinary marker for endogenous progesterone levels and as an indicator of ovulation. PDL exists as two isomers, 5a-pregnanediol and 5b-pregnanediol. 5b-pregnanediol represents the majority end point of endogenous progesterone metabolism and appears to have little activity within the body, while 5α-pregnanediol, the lesser metabolite of PDL, can cross the blood brain barrier and may partially agonize GABA-A receptors. This action is possibly due to its role as an immediate precursor to allopregnanolone. Allopregnanolone is a potent neuroactive steroid capable of binding the GABA-A receptor often leading to sedative and anxiolytic action. The calming action of allopregnanolone is often seen with orally supplemented progesterone, as the liver metabolizes a large portion of oral progesterone to the neuroactive steroid allopregnanolone.
5α-Pregnanediol is a urinary metabolite of progesterone that reflects luteal-phase progesterone output and the body’s 5α-reductase activity; on a HUMAP it’s best interpreted from a mid-luteal sample (~5–7 days after ovulation). Elevated levels may indicate robust luteal production, a 5α-dominant metabolism pattern, pregnancy, or exogenous progesterone use; low levels can suggest low luteal progesterone, non-luteal collection, or lower 5α activity. Always view it alongside 5β-pregnanediol and total progesterone metabolites, consider medications and hydration, and correlate with symptoms like PMS, sleep changes, spotting, or cycle length. Practical next steps include confirming timing and ovulation, considering serum mid-luteal progesterone if needed, and supporting ovulation quality through nutrition, stress and sleep, while checking thyroid, iron, and prolactin when cycles are irregular.
assesses androgen metabolism
a terminal metabolite of corticosterone
metabolite of cortisol
a terminal metabolite of cortisol metabolized via 5-alpha reductase
5a-Tetrahydrocortisol
alpha vs beta metabolism
The 5a-THF/THF Ratio reflects cortisol metabolism and 5a-reductase activity, helping assess adrenal function, stress response, and hormone balance.